Intensive short‐term chemotherapy regimen induces high remission rate (over 90%) and event‐free survival both in children and adult patients with advanced sporadic Burkitt lymphoma/leukemiaGiuseppe Todeschini, Giovanni Pizzolo, Giuseppe Carli et al.|American Journal of Hematology|2011Cited by 32
Dealing With High-Risk AL Amyloidosis Patients: A Single Hematologic Center ExperienceMarcello Riva, Fausto Adami, Tamara Berno et al.|Clinical Lymphoma Myeloma & Leukemia|2021Cited by 1